both are search shorthand for which reference compounds are included in the bundle
Ans: Injection frequency varies from one animal to the next, depending on the product, the condition being managed, and the pet's current health status
The primary methods are subcutaneous and intramuscular, with oral administration being explored for specific gut-related studies
These observations reinforce the need for well-designed randomised controlled trials (RCTs) to validate the findings and expand the evidence base
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
In addition, some peptides have FDA-approved medical uses, while others are prescribed off-label or remain investigational for wellness, performance, or longevity purposes
